Jundong Li

发表

Using machine learning to predict ovarian cancer

Taieb Znati, Xiao Zheng, Lujun Chen, 2020, Int. J. Medical Informatics.

Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer

Wei Wei, Xiaosu Zhu, Jibin Li, 2022, Journal for ImmunoTherapy of Cancer.

Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis

Yang-kui Gu, Jundong Li, Yun Zhou, 2016, International Journal of Gynecologic Cancer.

Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial.

Ji-Hong Liu, M. Zheng, Liguo Ma, 2021, JAMA oncology.

Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China

M. Zheng, Y. Xiong, Xin Huang, 2013, Archives of Gynecology and Obstetrics.

Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB–IIB cervical carcinoma: A retrospective study of 288 patients

Ji-Hong Liu, Hui-Yun Wang, M. Zheng, 2011, Journal of surgical oncology.

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer

Jiang Li, Jia He, Yanna Zhang, 2022, The Journal of clinical investigation.

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

Ji-Hong Liu, Yan Xiao, Meng-da Li, 2007, Ai zheng = Aizheng = Chinese journal of cancer.

Expression of c-Src and phospho-Src in epithelial ovarian carcinoma

C. Chen, Xiao-Feng Zhu, Juan Xiao, 2012, Molecular and Cellular Biochemistry.

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer

Qiang Yu, B. Teh, T. Kang, 2022, The Journal of clinical investigation.

A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases

J. Yun, Qiu-liang Wu, Jundong Li, 2011, Journal of Clinical Pathology.

Is Routine Gastroscopy/Colonoscopy Reasonable in Patients With Suspected Ovarian Cancer: A Retrospective Study

Junping Yan, Jundong Li, Guo-Chen Liu, 2021, Frontiers in Oncology.

[Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].

Jundong Li, He Huang, Yan-ling Feng, 2008, Ai zheng = Aizheng = Chinese journal of cancer.

Overexpression of ASAP 1 is associated with poor prognosis in epithelial ovarian cancer

Juan Xiao, Teng Hou, Chenlu Yang, 2013 .

Imaging features and clinical manifestations of neuromyelitis optica

Jing Guo, Jundong Li, Xiaoxia Zhao, 2021 .

miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway

Ming Chen, Juan Xiao, Hong-wei Shen, 2018, International journal of oncology.

Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial

W. Tian, Jingxian Shen, C. Xie, 2020, BMC Medicine.

Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.

M. Zheng, Jingxian Shen, Y. Xiong, 2018, The Lancet. Oncology.

Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling

Juan Xiao, Teng Hou, Chenlu Yang, 2015, Molecular medicine reports.

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Wei Wei, M. Zheng, Qing Liu, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

M. Zheng, Liguo Ma, Y. Xiong, 2020 .

Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.

Wei Wei, Jibin Li, Yong-wen Huang, 2021 .

Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.

Juan Xiao, Teng Hou, Chenlu Yang, 2014, International journal of clinical and experimental pathology.

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

J. Xia, M. Zheng, Linjing Yuan, 2018, Oncoimmunology.

Clinical significance of combined examination of pretreatment serum CYFRA 21-1 and SCCAg in cervical cancer patients

M. Zheng, Y. Xiong, Jundong Li, 2022 .

Clinical significance of combined examination of pretreatment serum CYFRA21-1 and SCCAg in cervical cancer patients.

M. Zheng, Y. Xiong, Jundong Li, 2009, Ai zheng = Aizheng = Chinese journal of cancer.

Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients.

Juan Xiao, Teng Hou, Jundong Li, 2013, International journal of clinical and experimental pathology.

Expression of c-Src and phospho-Src in epithelial ovarian carcinoma

Xiao-Feng Zhu, Juan Xiao, Yong-wen Huang, 2012, Molecular and Cellular Biochemistry.

The first Chinese National Union of Real‐world Gynaecological Oncology Research and Patient Management Platform: A retrospective study

Wei Wang, Ming Li, Ting Hu, 2022, BJOG : an international journal of obstetrics and gynaecology.

Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer

Wei Wei, D. Yao, Jundong Li, 2022, Frontiers in Oncology.

The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.

Yifan Meng, W. Ding, Peng Wu, 2023, The Lancet. Oncology.

Original Article Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer

Juan Xiao, Teng Hou, Sun Yat-sen, 2014 .